a public good project by the
Synthesis
Company
of California

© 2026

Nicholas Latimer | doi.page

0 works0 citations0 h-index

Nicholas Latimer

Delta Air Lines (United States)(US)Red Hat (United States)(US)University of British Columbia(CA)University of Sheffield(GB)

Publications by Year

Research Areas

Health Systems, Economic Evaluations, Quality of Life, Statistical Methods in Clinical Trials, Advanced Causal Inference Techniques, Pharmaceutical Economics and Policy, Economic and Financial Impacts of Cancer

Most-Cited Works

→ Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data(2013)520 cited
Osteoarthritis: national clinical guideline for care and management in adults(2008)
→ Self-managed, computerised speech and language therapy for patients with chronic aphasia post-stroke compared with usual care or attention control (Big CACTUS): a multicentre, single-blinded, randomised controlled trial(2019)190 cited
→ Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now?(2020)149 cited
→ Computer Therapy Compared With Usual Care for People With Long-Standing Aphasia Poststroke(2012)147 cited
→ Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods(2016)124 cited

→ Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study(2011)

116 cited

→ Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis(2009)114 cited

→ Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context(2014)101 cited

→ Adjusting for treatment switching in randomised controlled trials – A simulation study and a simplified two-stage method(2014)100 cited